Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
Fiche publication
Date publication
mai 2018
Journal
Urologia internationalis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BETTAIEB Ali
Tous les auteurs :
Ben Bahria-Sediki I, Chebil M, Sampaio C, Martel-Frachet V, Cherif M, Zermani R, Rammeh S, Ben Ammar Gaaied A, Bettaieb A
Lien Pubmed
Résumé
The activation of Fas/Fas ligand (FasL) and DR4-DR5/tumor necrosis factor-related-apoptosis-inducing ligand (TRAIL) pathways in cancer cells triggers apoptosis. The objective of this study was to investigate the prognostic value of soluble FasL (sFasL) and soluble (sTRAIL) in the serum of patients with bladder cancer.
Mots clés
Cell death, Serum soluble Fas ligand, Serum soluble tumor necrosis factor-related-apoptosis-inducing ligand, death receptors, Transitional cell carcinoma of bladder
Référence
Urol. Int.. 2018 May 2;:1-9